VEA
ICPT
Virtus ETF Advisers’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-25,272
| Closed | -$469K | – | 472 |
|
|
2023
Q3 | $469K | Sell |
25,272
-3,268
| -11% | -$60.6K | 0.28% | 175 |
|
|
2023
Q2 | $316K | Buy |
28,540
+7,922
| +38% | +$87.6K | 0.19% | 190 |
|
|
2023
Q1 | $277K | Buy |
20,618
+367
| +2% | +$4.93K | 0.15% | 259 |
|
|
2022
Q4 | $251K | Buy |
+20,251
| New | +$251K | 0.13% | 302 |
|
|
2021
Q4 | – | Sell |
-21,387
| Closed | -$318K | – | 406 |
|
|
2021
Q3 | $318K | Sell |
21,387
-1,966
| -8% | -$29.2K | 0.14% | 195 |
|
|
2021
Q2 | $466K | Buy |
23,353
+3,978
| +21% | +$79.4K | 0.19% | 172 |
|
|
2021
Q1 | $447K | Buy |
19,375
+526
| +3% | +$12.1K | 0.19% | 163 |
|
|
2020
Q4 | $466K | Buy |
18,849
+11,075
| +142% | +$274K | 0.19% | 142 |
|
|
2020
Q3 | $322K | Buy |
7,774
+655
| +9% | +$27.1K | 0.17% | 205 |
|
|
2020
Q2 | $341K | Buy |
7,119
+1,963
| +38% | +$94K | 0.16% | 275 |
|
|
2020
Q1 | $325K | Sell |
5,156
-435
| -8% | -$27.4K | 0.13% | 217 |
|
|
2019
Q4 | $693K | Sell |
5,591
-3,120
| -36% | -$387K | 0.11% | 155 |
|
|
2019
Q3 | $578K | Sell |
8,711
-1,469
| -14% | -$97.5K | 0.12% | 175 |
|
|
2019
Q2 | $810K | Buy |
10,180
+3,042
| +43% | +$242K | 0.17% | 182 |
|
|
2019
Q1 | $798K | Buy |
7,138
+1,578
| +28% | +$176K | 1.7% | 18 |
|
|
2018
Q4 | $560K | Sell |
5,560
-4,058
| -42% | -$409K | 0.1% | 65 |
|
|
2018
Q3 | $1.22M | Buy |
9,618
+648
| +7% | +$81.9K | 0.13% | 41 |
|
|
2018
Q2 | $753K | Sell |
8,970
-5,711
| -39% | -$479K | 0.67% | 68 |
|
|
2018
Q1 | $903K | Sell |
14,681
-861
| -6% | -$53K | 0.78% | 58 |
|
|
2017
Q4 | $908K | Buy |
15,542
+7,041
| +83% | +$411K | 1.14% | 41 |
|
|
2017
Q3 | $493K | Hold |
8,501
| – | – | 0.07% | 91 |
|
|
2017
Q2 | $1.03M | Sell |
8,501
-1,424
| -14% | -$172K | 0.15% | 62 |
|
|
2017
Q1 | $1.12M | Buy |
9,925
+954
| +11% | +$108K | 0.2% | 57 |
|
|
2016
Q4 | $975K | Buy |
8,971
+4,593
| +105% | +$499K | 0.29% | 53 |
|
|
2016
Q3 | $721K | Buy |
4,378
+552
| +14% | +$90.9K | 0.35% | 48 |
|
|
2016
Q2 | $546K | Buy |
3,826
+2,291
| +149% | +$327K | 0.41% | 37 |
|
|
2016
Q1 | $197K | Buy |
+1,535
| New | +$197K | 0.27% | 86 |
|